accelerated to grow. Regarding domestic demand, private consumption slowed down as a declining household income and employments, particularly in export-related manufacturing sectors. According to the slowdown
Summary for Q2’20 vs. Q2’19 OSP reported total revenue of THB 6,114 million, a decrease of 4.4% YoY, impacted by COVID-19 lockdown. The total revenue from sales decreased by 6.1% YoY to THB 5,909 million
Change Increase/(Decrease) For Three Months Period Ended 30 June 2017 2018 THB mm % THB mm % THB mm % Sale Revenue 1. Revenue from selling product under Company’s trademark 1) Facial skincare 404.57 77.96
or 12.2% from planned shutdown and decrease in unit rate which is adjusted in line with the decline in average natural gas price. Sales and service income for Q4/2020 compared to Q3/2020 decrease by
price. Nevertheless, the company had improved the feedstock management, resulting in the recorded adjusted EBITDA of THB 346 million, a little decrease from the previous year by 2%. In addition, the
, representing a decline of 22.1% Y-o-Y and decrease of 8.9% Q-o-Q. The Y-o-Y decrease was primarily attributed to the reduction in gross profit rate, the substantial effect of a change in foreign currency
majority of customers have slow down of investment. Gross Profit The Group's gross profit margin was 151 million baht in the first quarter of 2019, decrease of 97 million baht or 40% from the same period of
Limited and its subsidiaries have the revenues of 1,121.47 million baht, decrease of 0.74 %. The reasons for the decrease are : 1.1 In the year 2018, Ramkhamhaeng Hospital Public Company Limited and its
78,859 132,966 (40.7%) Finance costs - Interest expense 21,365 5,013 326.2% Net loss 185,535 163,997 13.1% Financial performance during the second quarter ended 30 June 2020 showed a decrease of Baht 149.3
Baht 4,015 million, a decline of 6.8 yoy while comprehensive income for the first nine months totaled Baht 3,886 million, also declining by 8.8%. Pre-provision operating profit for 3Q20 increased by 13.2